JP2004525873A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525873A5
JP2004525873A5 JP2002551496A JP2002551496A JP2004525873A5 JP 2004525873 A5 JP2004525873 A5 JP 2004525873A5 JP 2002551496 A JP2002551496 A JP 2002551496A JP 2002551496 A JP2002551496 A JP 2002551496A JP 2004525873 A5 JP2004525873 A5 JP 2004525873A5
Authority
JP
Japan
Prior art keywords
alkyl
amino
mono
alkoxy
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002551496A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525873A (ja
JP5260818B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/026816 external-priority patent/WO2002049993A2/en
Publication of JP2004525873A publication Critical patent/JP2004525873A/ja
Publication of JP2004525873A5 publication Critical patent/JP2004525873A5/ja
Application granted granted Critical
Publication of JP5260818B2 publication Critical patent/JP5260818B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002551496A 2000-09-29 2000-09-29 高親和性低分子C5a受容体調節物質 Expired - Fee Related JP5260818B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/026816 WO2002049993A2 (en) 2000-09-29 2000-09-29 High affinity small molecule c5a receptor modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011092825A Division JP2011219476A (ja) 2011-04-19 2011-04-19 高親和性低分子C5a受容体調節物質

Publications (3)

Publication Number Publication Date
JP2004525873A JP2004525873A (ja) 2004-08-26
JP2004525873A5 true JP2004525873A5 (cg-RX-API-DMAC7.html) 2007-11-22
JP5260818B2 JP5260818B2 (ja) 2013-08-14

Family

ID=21741822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002551496A Expired - Fee Related JP5260818B2 (ja) 2000-09-29 2000-09-29 高親和性低分子C5a受容体調節物質

Country Status (13)

Country Link
EP (1) EP1322309B1 (cg-RX-API-DMAC7.html)
JP (1) JP5260818B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030060887A (cg-RX-API-DMAC7.html)
CN (1) CN1454086A (cg-RX-API-DMAC7.html)
AT (1) ATE404553T1 (cg-RX-API-DMAC7.html)
AU (1) AU7622500A (cg-RX-API-DMAC7.html)
BR (1) BR0017338A (cg-RX-API-DMAC7.html)
DE (1) DE60039921D1 (cg-RX-API-DMAC7.html)
IL (1) IL154993A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03002788A (cg-RX-API-DMAC7.html)
NO (1) NO20031370L (cg-RX-API-DMAC7.html)
WO (1) WO2002049993A2 (cg-RX-API-DMAC7.html)
YU (1) YU23503A (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
CA2479928A1 (en) * 2002-03-28 2003-10-09 Neurogen Corporation Substituted biaryl amides as c5a receptor modulators
WO2003082828A1 (en) 2002-03-28 2003-10-09 Neurogen Corporation Substituted tetrahydroisoquinolines as c5a receptor modulators
US6858637B2 (en) 2002-03-28 2005-02-22 Neurogen Corporation Substituted biaryl amides as C5a receptor modulators
IL164355A0 (en) * 2002-03-29 2005-12-18 Neurogen Corp New aryl imidazoles and related compounds as cra receptor modulators
GB0214139D0 (en) * 2002-06-19 2002-07-31 Glaxo Group Ltd Chemical compounds
US7169775B2 (en) 2002-08-21 2007-01-30 Neurogen Corporation Amino methyl imidazoles as C5a receptor modulators
KR100863667B1 (ko) * 2002-09-11 2008-10-15 가부시끼가이샤 구레하 아민 화합물 및 그 용도
AU2003291403A1 (en) 2002-11-08 2004-06-03 Neurogen Corporation 3-substituted-6-aryl pyridined as ligands of c5a receptors
EP2266606B1 (en) 2003-05-15 2014-09-10 Genentech, Inc. Methods and compositions for the prevention and treatment of sepsis
KR101149124B1 (ko) 2004-03-10 2012-05-25 가부시끼가이샤 구레하 아민계 염기성 화합물과 그의 용도
WO2006012373A2 (en) * 2004-07-20 2006-02-02 Critical Therapeutics, Inc. Combination therapies of hmgb and complement inhibitors against inflammation
JP2007284352A (ja) * 2004-08-05 2007-11-01 Dai Ichi Seiyaku Co Ltd ピラゾール誘導体
KR20070084574A (ko) 2004-12-01 2007-08-24 칼립시스, 인코포레이티드 유도가능 산화질소 신타제 이량체화 억제제
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
EP1739078A1 (de) 2005-05-30 2007-01-03 Jerini AG C5a-Rezeptor-Antagonisten
JP5819730B2 (ja) 2008-12-22 2015-11-24 ケモセントリックス,インコーポレイティド C5aRアンタゴニスト
DK2585064T3 (en) 2010-06-24 2017-07-24 Chemocentryx Inc C5aR antagonists
US10233179B2 (en) * 2013-04-22 2019-03-19 Abbvie Inc. Thiazoles and uses thereof
JP6898229B6 (ja) 2014-09-29 2021-07-28 ケモセントリックス,インコーポレイティド C5aRアンタゴニスト製造における方法及び中間体
EP3072891A1 (en) * 2015-03-24 2016-09-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. New Toll-Like Receptor 9 Antagonists
SG11201805828YA (en) 2016-01-14 2018-08-30 Chemocentryx Inc Method of treating c3 glomerulopathy
SG11201808625QA (en) 2016-04-04 2018-10-30 Chemocentryx Inc SOLUBLE C5aR ANTAGONISTS
KR102638253B1 (ko) 2017-05-31 2024-02-16 케모센트릭스, 인크. C5a 억제제로서의 6-5 융합 고리
JP7141129B2 (ja) 2017-05-31 2022-09-22 ケモセントリックス,インコーポレイティド C5a阻害剤としての5-5融合環
CN111741754A (zh) 2017-10-30 2020-10-02 凯莫森特里克斯股份有限公司 作为免疫调节剂的氘代化合物
MX2020006459A (es) 2017-12-22 2020-11-06 Chemocentryx Inc Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar.
MA51327A (fr) 2017-12-22 2021-05-26 Chemocentryx Inc Composés cycliques fusionnés en 5,5 à substitution diaryle, utilisés en tant qu'inhibiteurs du c5ar
ES2993034T3 (en) 2018-04-02 2024-12-20 Chemocentryx Inc Prodrugs of fused-bicyclic c5ar antagonists
CN114957165A (zh) * 2021-02-26 2022-08-30 清华大学 一种抗病毒化合物及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6157590A (ja) * 1984-08-29 1986-03-24 Asahi Shiyueebell Kk シラン化合物およびその製造法
US5159083A (en) * 1990-12-28 1992-10-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands
US5681956A (en) * 1990-12-28 1997-10-28 Neurogen Corporation 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
MX9308025A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
EP0793653A1 (en) * 1994-11-23 1997-09-10 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
GB9426103D0 (en) * 1994-12-23 1995-02-22 Merck Sharp & Dohme Therapeutic agents
US6391874B1 (en) * 1996-07-13 2002-05-21 Smithkline Beecham Corporation Fused heterocyclic compounds as protein tyrosine kinase inhibitors
ATE318841T1 (de) * 1997-05-29 2006-03-15 Merck & Co Inc Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
MY153569A (en) * 1998-01-20 2015-02-27 Mitsubishi Tanabe Pharma Corp Inhibitors of ?4 mediated cell adhesion
AU2854399A (en) * 1998-03-20 1999-10-18 Daiichi Suntory Pharma Co., Ltd NF-kappa inhibitors containing as the active ingredient phenylmethyl benzoquinone
EP1080078B1 (en) * 1998-05-22 2006-02-01 Scios Inc. Heterocyclic compounds and methods to treat cardiac failure and other disorders
CA2336806A1 (en) * 1998-07-10 2000-01-20 Keith Russell N-substituted naphthalene carboxamides as neurokinin-receptor antagonists
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
IL141456A0 (en) * 1998-08-21 2002-03-10 Viropharma Inc Rhodanine derivatives and pharmaceutical compositions containing the same
US6437146B1 (en) * 1998-09-25 2002-08-20 Fujisawa Pharmaceutical Co., Ltd. Oxazole compounds as prostaglandin e2 agonists or antagonists
AU764479B2 (en) * 1998-10-29 2003-08-21 Bristol-Myers Squibb Company Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme
US6503905B1 (en) * 1998-12-29 2003-01-07 Pfizer Inc 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
IL145401A0 (en) * 1999-03-24 2002-06-30 Anormed Inc Chemokine receptor binding heterocyclic compounds
US6369226B1 (en) * 1999-06-21 2002-04-09 Agouron Pharmaceuticals, Inc. Substituted benzamide inhibitors of rhinovirus 3C protease
ES2270867T3 (es) * 1999-09-23 2007-04-16 Astrazeneca Ab Compuestos de quinazolina terapeuticos.
KR20030034184A (ko) * 2000-09-15 2003-05-01 아노르메드 인코포레이티드 케모킨 수용체 결합 헤테로사이클릭 화합물

Similar Documents

Publication Publication Date Title
US10653674B2 (en) Multisubstituted aromatic compounds as inhibitors of thrombin
EP1322309B1 (en) High affinity small molecule c5a receptor modulators
KR101214665B1 (ko) 트리아졸 유도체 또는 그의 염
JP4632544B2 (ja) アミノピラゾール誘導体
JP2002511463A (ja) インテグリンのそれの受容体への結合を阻害するn,n−ジ置換アミド
TW415940B (en) Condensed cyclic carboxylic acid compound or salt thereof, and medical composition containing which
HUP0104364A2 (hu) Pirrolidinszármazékok, CCR-3 receptor antagonisták és ezeket tartalmazó gyógyszerkészítmények
JPH09501404A (ja) 新規化合物
KR20070007361A (ko) 1-아미노-프탈라진 유도체, 이의 제조 방법 및 치료적 용도
KR20060095865A (ko) 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
JP2007507529A (ja) 複素環式アミドおよびスルホンアミド
WO2010084767A1 (en) N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
RS54737B1 (sr) Derivati benzazola kao veznici h4 receptora histamina
CA2569654A1 (en) Benzimidazolone carboxylic acid derivatives
RU2453540C2 (ru) 2,3-замещенные пиразинсульфонамиды в качестве ингибиторов crth2
JP2003528854A (ja) 医薬として活性なピロリジン誘導体
KR20070054215A (ko) 벤즈이미다졸 유도체, 그를 함유하는 조성물, 그의 제조방법 및 그의 용도
AU2003228419A1 (en) New aryl imidazoles and related compounds as c5a receptor modulators
WO2006106812A1 (ja) プロパン-1,3-ジオン誘導体又はその塩
JP2007186422A (ja) アリールスルフィド誘導体
EP2814814B1 (en) Imidazolylketone derivatives asd aldosterone synthase inhibitors
RU2003105218A (ru) Малые молекулы модуляторов рецепторов с5а высокой аффинности
JP2011219476A (ja) 高親和性低分子C5a受容体調節物質
JP2002532473A (ja) 5−ht1a受容体活性を有する1,4−ピペラジン誘導体
JP2004083511A (ja) アクリルアミド誘導体